Daniel LeSueur, Chief Operating Officer at Health Catalyst, Inc. (HCAT), sold 45,546 shares at $7.70 ($351K) on 2024-12-04, disclosed to the SEC on 2024-12-06.
Scheduled sale ($351k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.70 | 22,773 | $175K | 50.0% |
| 2 | $7.70 | 22,773 | $175K | 50.0% |
| Total | $7.70 avg | 45,546 | $351K | 100% |
| Filing → |
| HCAT | SELL | 2025-03-10 | $153K | — | Filing → |
| HCAT | SELL | 2025-02-06 | $30K | — | Filing → |
| HCAT | SELL | 2025-01-10 | $39K | — | Filing → |